Intro

This chapter explores the historical context and resurgence of muscarinic agonists as potential therapies for schizophrenia. The discussion highlights early research from the 1950s and its overshadowing by dopamine-focused treatments, setting the stage for recent discoveries in the field.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app